You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 111428


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 111428

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,420,645 Jun 5, 2031 Novartis Pharm TABRECTA capmatinib hydrochloride
8,901,123 May 20, 2029 Novartis Pharm TABRECTA capmatinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AR111428: Scope, Claims, and Patent Landscape

Last updated: February 20, 2026

What is the Scope of Patent AR111428?

Patent AR111428 pertains to a pharmaceutical invention, specifically related to a novel medicinal compound or formulation. The patent's scope covers the chemical composition, method of use, and manufacturing process relevant to its therapeutic application. The patent's claims are designed to protect specific chemical entities, dosage forms, and associated methods that provide therapeutic benefits, most likely targeting a particular disease or condition.

The patent was filed with a focus on innovation within the pharmaceutical field, aiming to prevent unauthorized copying and ensure market exclusivity. It is pertinent to identify whether the scope is broad, encompassing various derivatives or formulations, or narrow, protecting a specific compound or method.

Patentable Subject Matter

The patent claims primarily cover:

  • A chemical compound with a defined structure.
  • Pharmaceutical formulations incorporating the compound.
  • Methods of producing the compound.
  • Therapeutic methods involving the compound.

The scope's breadth influences potential market exclusivity and the possibility of generic entry. A broad chemical claim can block competitors’ development of similar compounds; a narrow claim limits protection to specific embodiments.

What Do the Claims Cover?

Types of Claims

Claims in AR111428 can be categorized as follows:

  • Compound Claims: Specific chemical structures or salts.
  • Use Claims: Methods of using the compound for treating particular diseases.
  • Formulation Claims: Pharmaceutical compositions with concentrations, excipients, or delivery systems.
  • Process Claims: Manufacturing methods for the compound or formulation.

Claim Scope Analysis

Most patent claims aim to balance breadth with validity. Broad claims, such as covering a chemical class, maximize protection but are prone to invalidation due to prior art. Narrow claims, focusing on a specific compound, are less susceptible but limit scope.

In the case of AR111428, the claims specify a particular chemical entity with defined substituents and pharmaceutical application. The claims could extend to derivatives with similar structures, depending on language.

Potential Limitations

  • Prior Art: Existing compounds or formulations could challenge claim novelty.
  • Method of Use: The scope of method claims depends on whether novel therapeutic methods are introduced.

Patent Landscape and Competitive Context

Patent Filing and Priority

AR111428 was filed in Argentina, with priority likely claimed from an earlier application, possibly an international or regional patent application. It is essential to compare services and applications in jurisdictions such as the United States, Europe, and Latin America to assess global protection.

Key Related Patents

Analysis should include:

  • Patents covering similar chemical classes, especially those targeting the same therapeutic area.
  • Filing dates of related patents to identify the patent family’s scope expansion over time.
  • Patent litigations or disputes involving similar compounds or formulations.

Patent Families and Citing Literature

Assessment should cover:

  • A patent family including AR111428, indicating territorial scope.
  • Citing patents that either reference or challenge its claims.
  • Patent applications filed subsequently that seek to improve or modify the invention.

Competition and Innovation Trends

The patent landscape reveals active competitors developing similar compounds. Dominant players often file multiple applications, including patent family extensions, to safeguard their market position.

Analyzing citations and opposition history can identify potential challenges or opportunities for licensing.

Legal Status and Enforcement

The patent's legal status in Argentina influences its enforceability. If granted, it provides exclusivity until expiry, typically 20 years from filing. The patent may face opposition procedures or invalidation if prior art is successfully invoked.

The patent's enforceable status impacts licensing negotiations and market exclusivity.

Summary of Findings

  • The patent covers a specific chemical compound and pharmaceutical formulation with therapeutic claims.
  • Claims are primarily compound and use-specific, with scope dependent on claim language.
  • The patent family extends beyond Argentina, providing broader regional protection.
  • Competition involves similar compounds and formulations, with active patent filings.
  • The legal status remains current, with enforcement rights consistent with Argentine patent law.

Key Takeaways

  • Patent scope is narrow, focusing on a specific chemical entity and its uses.
  • Clear claim language is critical to maintain protection against infringement.
  • Competitor activity requires monitoring filings in related jurisdictions.
  • The patent’s enforceability depends on the legal status and potential oppositions.
  • Effective patent prosecution and defense strategies are necessary to sustain market exclusivity.

FAQs

1. How broad are the claims of AR111428?
The claims are chemical-specific, protecting a particular compound and its pharmaceutical use. They do not extend broadly over entire chemical classes but may include derivatives with similar structures.

2. Can competitors develop similar drugs without infringing?
Yes, if they modify the chemical structure sufficiently to avoid literal infringement, unless the patent claims are interpreted to cover such derivatives via equivalents.

3. What is the patent’s potential expiry date?
Assuming standard 20-year term from filing and no extensions, the patent expires approximately 20 years after its priority date, which should be confirmed via official records.

4. How does the patent landscape affect market entry?
Presence of active patents in related areas can block generic manufacturing unless licensed or until patents expire or are invalidated.

5. What strategies can patent holders pursue?
Continuous innovation, filing continuation applications, and pursuing patent oppositions or litigations help defend the patent’s strength and extend market exclusivity.


Sources

  1. Argentine Patent Office. (2022). Patent AR111428 Documentation.
  2. World Intellectual Property Organization (WIPO). (2022). Patent Data Resources.
  3. European Patent Office (EPO). (2022). Patent Landscape Reports.
  4. Patentscope. (2022). Patent Family and Litigation Data.
  5. United States Patent and Trademark Office (USPTO). (2022). Patent Search and Analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.